Connect
MJA
MJA

Pharmacological treatment of cognitive deficits in Alzheimer's disease

William Lam
Med J Aust 2002; 176 (6): 297.
Published online: 18 March 2002

To the Editor: The review by Brodaty and colleagues1 on drug treatment of Alzheimer's disease provides a good, concise and balanced overview. However, Pfizer takes issue with some of the referenced safety data.

  • William Lam

  • Pfizer Pty Ltd, West Ryde, NSW.

Correspondence: Bill.Lam@Pfizer.com

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.